{
    "address": "Uppsala Business Park, Virdings alle 32 B",
    "city": "Uppsala",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W1552W104",
    "description": "AroCell AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2011-05-25. The firm's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Life Sciences Tools & Services",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Life Sciences Tools & Services",
    "gsector": "Health Care",
    "gsubind": "Life Sciences Tools & Services",
    "ipo": "2011-05-25",
    "isin": "SE0003883990",
    "logo": "",
    "marketCapitalization": 526.4148,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in Biotechnology",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "AroCell AB (publ)",
    "phone": "4618503020.0",
    "sedol": "B42L149",
    "shareOutstanding": 75.712408,
    "state": "UPPSALA",
    "ticker": "AROC.ST",
    "weburl": "https://www.arocell.com/"
}